Table of Contents
Top 6 Equity - Sectoral Funds
An equity fund is a mutual fund that invests principally in stocks. It can be actively or passively (index fund) managed. These are also known as stock funds.
Equity Funds should be the vehicle of choice when Investing for long-term goals as they have created huge profits for investors in the past few years. But as there is a wide choice before investors, choosing the right equity fund becomes critical.
With right qualitative and quantitative measures (discussed below), one can ideally choose the best equity Mutual Funds to invest.
Since stocks are actively traded across all major exchanges, every day, this makes equity funds a highly liquid investment. It provides investors, the convenience of buying and selling their stocks depending on the market situation. By investing in equity mutual funds, the money is usually credited to your Bank account in 3 days.
Investing into blue-chip companies may help investors earn a steady Income in the form of dividends. A majority of such companies usually pay out regular dividends even in volatile market conditions, typically paid quarterly. Having a diversified portfolio can provide investors with a steady dividend income in the year.
With best equity mutual funds investors can diversify their portfolio through regularly investing. It means that they can invest in stocks of different economic sectors. So, even if a particular stock drops in value, the others may help investors make up for that loss depending on the market situation.
In many ways, equity funds are ideal investment vehicles for investors that are not as well-versed in financial investing or do not possess a large amount of Capital with which to invest. They are practical investments for most people.
The attributes that make equity funds most suitable for small individual investors are the reduction of risk resulting from a fund's portfolio diversification and the relatively small amount of capital required to acquire shares of an equity fund. A large amount of investment capital would be required for an individual investor to achieve a similar degree of risk reduction through diversification of a portfolio of direct stock holdings. Pooling small investors capital allows an equity fund to diversify effectively without burdening each investor with large capital requirements.
The price of the equity fund is based on the fund's net asset value (NAV) less its liabilities. A more diversified fund means that there is less negative effect of an individual stock's adverse price movement on the overall portfolio and on the share price of the equity fund.
Equity funds are managed by experienced professional portfolio managers, and their past performance is a matter of public record. Transparency and reporting requirements for equity funds are heavily regulated by the Security Exchange Board of India (SEBI)
Talk to our investment specialist
Best equity mutual funds are categorised according to its types- ELSS, Large cap funds, mid cap funds, Small cap funds, Diversified Funds, sector funds and Balanced Fund.
Fund NAV Net Assets (Cr) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 5 YR (%) 2020 (%) Axis Bluechip Fund Growth ₹38.88
↑ 0.66 ₹22,517 21.3 30.3 19 15 16.9 19.7 Canara Robeco Bluechip Equity Fund Growth ₹34.45
↑ 0.51 ₹1,364 21.1 30.7 23.7 14.2 16.6 23.1 BNP Paribas Large Cap Fund Growth ₹117.58
↑ 1.67 ₹1,051 21 28.5 17.7 9.9 13.7 16.8 Kotak Bluechip Fund Growth ₹305.448
↑ 4.30 ₹2,067 20.9 31.7 18.5 9.7 14.1 16.4 SBI Bluechip Fund Growth ₹50.3164
↑ 0.84 ₹25,925 26 35.7 19.1 8.4 13.5 16.3 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 19 Jan 21
Fund NAV Net Assets (Cr) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 5 YR (%) 2020 (%) Axis Mid Cap Fund Growth ₹50.97
↑ 0.85 ₹8,515 20.7 32.2 24.6 13.3 17.3 26 PGIM India Midcap Opportunities Fund Growth ₹28.63
↑ 0.57 ₹604 26 48 47.6 11.3 15.1 48.4 Invesco India Mid Cap Fund Growth ₹65.2
↑ 1.13 ₹1,228 22.6 35.2 23.6 8.1 15.3 24.4 DSP BlackRock Midcap Fund Growth ₹73.542
↑ 1.15 ₹9,823 19.8 32.1 22 7.7 16.7 23.6 Kotak Emerging Equity Scheme Growth ₹51.611
↑ 0.88 ₹9,016 25.2 40.6 20.8 7 16.5 21.9 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 19 Jan 21
Fund NAV Net Assets (Cr) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 5 YR (%) 2020 (%) Kotak Small Cap Fund Growth ₹102.655
↑ 1.35 ₹2,372 27.8 55.6 31.5 6.8 16.1 34.2 SBI Small Cap Fund Growth ₹73.6772
↑ 1.07 ₹6,628 26.1 47.1 30.9 5.1 18.9 33.6 Nippon India Small Cap Fund Growth ₹51.6505
↑ 0.72 ₹10,916 25.2 45 23.8 2.2 15.9 29.2 ICICI Prudential Smallcap Fund Growth ₹32.7
↑ 0.42 ₹1,778 26 48.6 19.7 2.2 12.2 22.8 DSP BlackRock Small Cap Fund Growth ₹72.804
↑ 1.00 ₹6,001 22 43.7 25.1 0.5 13 33.1 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 19 Jan 21
Fund NAV Net Assets (Cr) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 5 YR (%) 2020 (%) Mirae Asset Emerging Bluechip Fund Growth ₹74.382
↑ 1.22 ₹14,302 24.6 37.1 24.6 11.6 20.6 22.4 Invesco India Growth Opportunities Fund Growth ₹42.88
↑ 0.71 ₹3,472 19.6 30.9 14.9 8.7 15 13.3 Kotak Equity Opportunities Fund Growth ₹154.712
↑ 2.14 ₹4,633 20.1 29.7 16.3 8.7 15.7 16.5 Edelweiss Large and Mid Cap Fund Growth ₹40.322
↑ 0.64 ₹615 22 33.6 18.7 8.6 14.3 17 Canara Robeco Emerging Equities Growth ₹124.3
↑ 1.84 ₹7,313 22.2 35.1 23.6 8.3 17.4 24.5 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 19 Jan 21
Fund NAV Net Assets (Cr) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 5 YR (%) 2020 (%) Canara Robeco Equity Tax Saver Growth ₹90.51
↑ 1.43 ₹1,476 21 35.8 29.3 14.1 16.7 27.4 Mirae Asset Tax Saver Fund Growth ₹24.277
↑ 0.39 ₹5,489 23.4 37.6 23.9 11.7 20.8 21.5 Axis Long Term Equity Fund Growth ₹59.7834
↑ 1.09 ₹27,181 25.5 35.1 18.7 11.4 15.9 20.5 Invesco India Tax Plan Growth ₹65.84
↑ 1.06 ₹1,386 20.8 30.9 19.6 9.1 14.9 19.2 Kotak Tax Saver Fund Growth ₹55.7
↑ 0.76 ₹1,527 19.7 30.6 14.7 8.7 15 14.9 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 19 Jan 21
Fund NAV Net Assets (Cr) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 5 YR (%) 2020 (%) UTI Equity Fund Growth ₹204.835
↑ 3.49 ₹14,861 26.7 42.3 30.8 15 17.2 31.5 Parag Parikh Long Term Equity Fund Growth ₹35.7861
↑ 0.22 ₹6,393 12.3 25.6 30.3 14.1 17.5 32.3 PGIM India Diversified Equity Fund Growth ₹19.61
↑ 0.25 ₹503 23.3 37.5 35 12.2 15.9 35.9 Canara Robeco Equity Diversified Growth ₹178.23
↑ 2.65 ₹3,056 19.2 30.5 22.2 12 15.9 22.2 DSP BlackRock Equity Fund Growth ₹52.517
↑ 0.82 ₹4,613 25.8 33.6 18.9 9.6 16 18.7 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 19 Jan 21
Fund NAV Net Assets (Cr) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 5 YR (%) 2020 (%) ICICI Prudential Technology Fund Growth ₹102.16
↑ 0.53 ₹1,185 21.4 61.5 68.6 26.9 20.6 70.6 Nippon India Pharma Fund Growth ₹256.45
↑ 4.28 ₹4,383 12.9 29.6 63.7 21 13.2 66.4 SBI Healthcare Opportunities Fund Growth ₹200.814
↑ 3.21 ₹1,575 12.6 31.5 62.6 15 8 65.8 UTI Healthcare Fund Growth ₹142.904
↑ 1.96 ₹649 10.6 29.7 61.1 16.3 10 67.4 TATA India Pharma & Healthcare Fund Growth ₹15.1985
↑ 0.26 ₹419 12.1 30.5 58.6 19 9.4 64.4 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 19 Jan 21
Fund NAV Net Assets (Cr) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 5 YR (%) 2020 (%) IIFL Focused Equity Fund Growth ₹23.3726
↑ 0.37 ₹1,353 24.1 36.4 25.8 14.7 18.6 23.8 Axis Focused 25 Fund Growth ₹37.59
↑ 0.69 ₹14,358 24.5 34.5 19.1 11.2 18.3 21 Principal Focused Multicap Fund Growth ₹85.35
↑ 1.58 ₹483 23.4 30.4 21.4 10.4 15.1 19.7 Motilal Oswal Focused 25 Fund Growth ₹29.3591
↑ 0.46 ₹1,548 20.9 31.7 19.7 9.9 14.5 17.3 Sundaram Select Focus Fund Growth ₹225.041
↑ 3.65 ₹1,185 21.3 28.6 14.3 9.7 14.4 11.9 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 19 Jan 21
Fund NAV Net Assets (Cr) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 5 YR (%) 2020 (%) UTI Dividend Yield Fund Growth ₹81.6472
↑ 1.04 ₹2,531 20.6 27.8 21.1 8 13.9 18.9 Principal Dividend Yield Fund Growth ₹67.94
↑ 1.02 ₹187 21.6 29.8 21 7.2 16.4 20.2 Templeton India Equity Income Fund Growth ₹59.4727
↑ 0.74 ₹939 26.8 41 24 6.1 14.4 22.9 Aditya Birla Sun Life Dividend Yield Fund Growth ₹192.33
↑ 1.97 ₹742 18 25.4 13.1 0.9 9.1 16.1 ICICI Prudential Dividend Yield Equity Fund Growth ₹18.8
↑ 0.28 ₹207 26.9 29.9 14.4 0 11.5 14.1 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 19 Jan 21
Fund NAV Net Assets (Cr) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 5 YR (%) 2020 (%) UTI Value Opportunities Fund Growth ₹80.5073
↑ 1.28 ₹5,202 25.3 35.4 21.2 9.7 13.9 19 ICICI Prudential Value Discovery Fund Growth ₹185.66
↑ 2.57 ₹17,443 25.5 31.3 26.7 7.3 12.2 22.9 JM Value Fund Growth ₹39.9111
↑ 0.80 ₹128 28.3 34.2 14.6 5.5 15.7 13.4 Nippon India Value Fund Growth ₹91.5196
↑ 1.51 ₹3,322 24.9 36.9 18.8 5.2 13.3 16.3 Tata Equity PE Fund Growth ₹161.208
↑ 2.02 ₹4,620 16.9 27.4 14.2 4.1 15.2 12.5 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 19 Jan 21
*Below is list of Equity Funds
having AUM >= 50 Crore
having best returns in last 1 Year
.
To generate long-term capital appreciation for you from a portfolio made up predominantly of equity and equity-related securities of technology intensive companies. ICICI Prudential Technology Fund is a Equity - Sectoral fund was launched on 3 Mar 00. It is a fund with High risk and has given a Below is the key information for ICICI Prudential Technology Fund Returns up to 1 year are on The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies. Nippon India Pharma Fund is a Equity - Sectoral fund was launched on 5 Jun 04. It is a fund with High risk and has given a Below is the key information for Nippon India Pharma Fund Returns up to 1 year are on (Erstwhile SBI Pharma Fund) To provide the investors maximum growth opportunity through equity
investments in stocks of growth oriented sectors of the economy. SBI Healthcare Opportunities Fund is a Equity - Sectoral fund was launched on 31 Dec 04. It is a fund with High risk and has given a Below is the key information for SBI Healthcare Opportunities Fund Returns up to 1 year are on (Erstwhile UTI Pharma & Healthcare Fund) The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. UTI Healthcare Fund is a Equity - Sectoral fund was launched on 28 Jun 99. It is a fund with High risk and has given a Below is the key information for UTI Healthcare Fund Returns up to 1 year are on The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns. TATA India Pharma & Healthcare Fund is a Equity - Sectoral fund was launched on 28 Dec 15. It is a fund with High risk and has given a Below is the key information for TATA India Pharma & Healthcare Fund Returns up to 1 year are on To provide long-term capital appreciation by predominantly investing in equity and equity related securities of technology and technology related companies. Franklin India Technology Fund is a Equity - Sectoral fund was launched on 22 Aug 98. It is a fund with High risk and has given a Below is the key information for Franklin India Technology Fund Returns up to 1 year are on 1. ICICI Prudential Technology Fund
CAGR/Annualized
return of 11.8% since its launch. Ranked 37 in Sectoral
category. Return for 2020 was 70.6% , 2019 was 2.3% and 2018 was 19.1% . ICICI Prudential Technology Fund
Growth Launch Date 3 Mar 00 NAV (19 Jan 21) ₹102.16 ↑ 0.53 (0.52 %) Net Assets (Cr) ₹1,185 on 31 Dec 20 Category Equity - Sectoral AMC ICICI Prudential Asset Management Company Limited Rating ☆☆ Risk High Expense Ratio 2.6 Sharpe Ratio 1.59 Information Ratio -0.49 Alpha Ratio 6.17 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Dec 15 ₹10,000 31 Dec 16 ₹9,603 31 Dec 17 ₹11,505 31 Dec 18 ₹13,704 31 Dec 19 ₹14,026 31 Dec 20 ₹23,927 Returns for ICICI Prudential Technology Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 19 Jan 21 Duration Returns 1 Month 8.7% 3 Month 21.4% 6 Month 61.5% 1 Year 68.6% 3 Year 26.9% 5 Year 20.6% 10 Year 15 Year Since launch 11.8% Historical performance (Yearly) on absolute basis
Year Returns 2020 70.6% 2019 2.3% 2018 19.1% 2017 19.8% 2016 -4% 2015 3.9% 2014 26.3% 2013 62.6% 2012 17.1% 2011 -18.9% Fund Manager information for ICICI Prudential Technology Fund
Name Since Tenure Sankaran Naren 14 Jul 17 3.47 Yr. Priyanka Khandelwal 8 Jul 20 0.48 Yr. Vaibhav Dusad 2 May 20 0.67 Yr. Data below for ICICI Prudential Technology Fund as on 31 Dec 20
Equity Sector Allocation
Sector Value Technology 67.26% Communication Services 16.32% Industrials 9.44% Consumer Cyclical 1.26% Financial Services 0.83% Consumer Defensive 0.74% Health Care 0.53% Asset Allocation
Asset Class Value Cash 3.62% Equity 96.38% Top Securities Holdings / Portfolio
Name Holding Value Quantity Infosys Ltd (Technology)
Equity, Since 30 Apr 08 | INFY21% ₹247 Cr 1,966,037
↑ 40,000 HCL Technologies Ltd (Technology)
Equity, Since 30 Sep 20 | HCLTECH8% ₹98 Cr 1,039,744
↑ 260,000 Tech Mahindra Ltd (Technology)
Equity, Since 31 Oct 16 | 5327556% ₹73 Cr 749,505
↑ 126,374 Persistent Systems Ltd (Technology)
Equity, Since 31 May 20 | PERSISTENT4% ₹48 Cr 317,847
↑ 79,802 Bharti Airtel Ltd (Communication Services)
Equity, Since 31 May 20 | BHARTIARTL4% ₹48 Cr 936,840
↓ -50,000 IndiaMART InterMESH Ltd (Communication Services)
Equity, Since 30 Jun 20 | 5427264% ₹43 Cr 66,804
↑ 4,000 Tata Consultancy Services Ltd (Technology)
Equity, Since 30 Sep 19 | TCS3% ₹34 Cr 120,185 Cyient Ltd (Industrials)
Equity, Since 30 Jun 18 | CYIENT3% ₹34 Cr 657,374
↑ 52,966 Coforge Ltd (Technology)
Equity, Since 31 Jul 20 | 5325413% ₹32 Cr 118,903
↓ -10,000 Firstsource Solutions Ltd (Technology)
Equity, Since 31 Aug 20 | 5328093% ₹31 Cr 3,049,435
↓ -100,000 2. Nippon India Pharma Fund
CAGR/Annualized
return of 21.6% since its launch. Ranked 35 in Sectoral
category. Return for 2020 was 66.4% , 2019 was 1.7% and 2018 was 3.6% . Nippon India Pharma Fund
Growth Launch Date 5 Jun 04 NAV (19 Jan 21) ₹256.45 ↑ 4.28 (1.70 %) Net Assets (Cr) ₹4,383 on 31 Dec 20 Category Equity - Sectoral AMC Nippon Life Asset Management Ltd. Rating ☆☆ Risk High Expense Ratio 2.13 Sharpe Ratio 1.79 Information Ratio 1.16 Alpha Ratio 6.62 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Dec 15 ₹10,000 31 Dec 16 ₹8,942 31 Dec 17 ₹9,623 31 Dec 18 ₹9,973 31 Dec 19 ₹10,141 31 Dec 20 ₹16,878 Returns for Nippon India Pharma Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 19 Jan 21 Duration Returns 1 Month 2.7% 3 Month 12.9% 6 Month 29.6% 1 Year 63.7% 3 Year 21% 5 Year 13.2% 10 Year 15 Year Since launch 21.6% Historical performance (Yearly) on absolute basis
Year Returns 2020 66.4% 2019 1.7% 2018 3.6% 2017 7.6% 2016 -10.6% 2015 19.4% 2014 49.5% 2013 20.9% 2012 34.8% 2011 -11% Fund Manager information for Nippon India Pharma Fund
Name Since Tenure Sailesh Raj Bhan 1 Apr 05 15.76 Yr. Data below for Nippon India Pharma Fund as on 31 Dec 20
Equity Sector Allocation
Sector Value Health Care 97.72% Asset Allocation
Asset Class Value Cash 2.28% Equity 97.72% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 09 | SUNPHARMA11% ₹474 Cr 8,000,976 Aurobindo Pharma Ltd (Healthcare)
Equity, Since 31 Dec 15 | AUROPHARMA11% ₹461 Cr 5,000,000 Cipla Ltd (Healthcare)
Equity, Since 31 May 08 | 5000879% ₹410 Cr 5,000,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB9% ₹403 Cr 1,050,000
↓ -50,000 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 08 | 5002579% ₹391 Cr 4,000,025 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 30 Jun 11 | 5001249% ₹390 Cr 750,000
↑ 125,000 Cadila Healthcare Ltd (Healthcare)
Equity, Since 31 Jan 18 | 5323217% ₹286 Cr 5,998,982 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Aug 18 | 5328436% ₹248 Cr 16,003,541
↑ 1,600,000 Gland Pharma Ltd (Healthcare)
Equity, Since 30 Nov 20 | GLAND4% ₹191 Cr 814,523
↓ -458,241 Thyrocare Technologies Ltd (Healthcare)
Equity, Since 31 May 16 | THYROCARE4% ₹186 Cr 2,041,561
↓ -61,549 3. SBI Healthcare Opportunities Fund
CAGR/Annualized
return of 14.7% since its launch. Ranked 34 in Sectoral
category. Return for 2020 was 65.8% , 2019 was -0.5% and 2018 was -9.9% . SBI Healthcare Opportunities Fund
Growth Launch Date 31 Dec 04 NAV (19 Jan 21) ₹200.814 ↑ 3.21 (1.63 %) Net Assets (Cr) ₹1,575 on 31 Dec 20 Category Equity - Sectoral AMC SBI Funds Management Private Limited Rating ☆☆ Risk High Expense Ratio 2.37 Sharpe Ratio 1.87 Information Ratio -0.04 Alpha Ratio 8.2 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-15 Days (0.5%),15 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Dec 15 ₹10,000 31 Dec 16 ₹8,598 31 Dec 17 ₹8,775 31 Dec 18 ₹7,907 31 Dec 19 ₹7,868 31 Dec 20 ₹13,048 Returns for SBI Healthcare Opportunities Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 19 Jan 21 Duration Returns 1 Month 3.3% 3 Month 12.6% 6 Month 31.5% 1 Year 62.6% 3 Year 15% 5 Year 8% 10 Year 15 Year Since launch 14.7% Historical performance (Yearly) on absolute basis
Year Returns 2020 65.8% 2019 -0.5% 2018 -9.9% 2017 2.1% 2016 -14% 2015 27.1% 2014 56.8% 2013 26% 2012 37.1% 2011 -5.5% Fund Manager information for SBI Healthcare Opportunities Fund
Name Since Tenure Tanmaya Desai 1 Jun 11 9.59 Yr. Data below for SBI Healthcare Opportunities Fund as on 31 Dec 20
Equity Sector Allocation
Sector Value Health Care 98.56% Asset Allocation
Asset Class Value Cash 1.1% Equity 98.9% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMA10% ₹160 Cr 2,700,000
↑ 700,000 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 20 | 50012410% ₹156 Cr 300,000 Lupin Ltd (Healthcare)
Equity, Since 31 Jul 18 | 5002579% ₹147 Cr 1,500,000 Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | 5000879% ₹141 Cr 1,720,000
↓ -80,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB9% ₹138 Cr 360,000
↓ -20,000 Aurobindo Pharma Ltd (Healthcare)
Equity, Since 30 Apr 20 | AUROPHARMA9% ₹138 Cr 1,500,000
↓ -180,000 Narayana Hrudayalaya Ltd (Healthcare)
Equity, Since 31 Dec 19 | NH5% ₹72 Cr 1,600,000 Strides Pharma Science Ltd (Healthcare)
Equity, Since 31 Mar 14 | STAR4% ₹66 Cr 750,000
↓ -50,000 Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 Jul 20 | ALKEM4% ₹59 Cr 200,000
↑ 20,000 Abbott India Ltd (Healthcare)
Equity, Since 31 Mar 19 | 5004884% ₹55 Cr 35,000
↑ 10,000 4. UTI Healthcare Fund
CAGR/Annualized
return of 14.6% since its launch. Ranked 40 in Sectoral
category. Return for 2020 was 67.4% , 2019 was 1.2% and 2018 was -7.5% . UTI Healthcare Fund
Growth Launch Date 28 Jun 99 NAV (19 Jan 21) ₹142.904 ↑ 1.96 (1.39 %) Net Assets (Cr) ₹649 on 31 Dec 20 Category Equity - Sectoral AMC UTI Asset Management Company Ltd Rating ☆ Risk High Expense Ratio 2.59 Sharpe Ratio 1.81 Information Ratio 0.36 Alpha Ratio 6.74 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Dec 15 ₹10,000 31 Dec 16 ₹9,029 31 Dec 17 ₹9,589 31 Dec 18 ₹8,867 31 Dec 19 ₹8,971 31 Dec 20 ₹15,014 Returns for UTI Healthcare Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 19 Jan 21 Duration Returns 1 Month 1.4% 3 Month 10.6% 6 Month 29.7% 1 Year 61.1% 3 Year 16.3% 5 Year 10% 10 Year 15 Year Since launch 14.6% Historical performance (Yearly) on absolute basis
Year Returns 2020 67.4% 2019 1.2% 2018 -7.5% 2017 6.2% 2016 -9.7% 2015 12.4% 2014 43.7% 2013 23.3% 2012 24.8% 2011 -9.6% Fund Manager information for UTI Healthcare Fund
Name Since Tenure V Srivatsa 3 Mar 17 3.83 Yr. Data below for UTI Healthcare Fund as on 31 Dec 20
Equity Sector Allocation
Sector Value Health Care 94.5% Basic Materials 2.22% Asset Allocation
Asset Class Value Cash 3.27% Equity 96.73% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA10% ₹67 Cr 1,132,558
↓ -106,562 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | 5001249% ₹58 Cr 110,782
↓ -3,408 Aurobindo Pharma Ltd (Healthcare)
Equity, Since 31 Oct 13 | AUROPHARMA9% ₹58 Cr 624,369
↑ 55,822 Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 5000878% ₹54 Cr 654,227
↑ 15,676 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB7% ₹43 Cr 111,549
↓ -13,534 Eris Lifesciences Ltd Registered Shs (Healthcare)
Equity, Since 31 Mar 19 | 5405965% ₹34 Cr 578,554
↑ 88,828 Cadila Healthcare Ltd (Healthcare)
Equity, Since 31 Jan 03 | 5323215% ₹32 Cr 667,045
↓ -89,236 Narayana Hrudayalaya Ltd (Healthcare)
Equity, Since 31 Jan 20 | NH4% ₹26 Cr 580,716
↓ -34,154 Biocon Ltd (Healthcare)
Equity, Since 31 Oct 18 | 5325234% ₹24 Cr 516,118 Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | 5323313% ₹23 Cr 137,818
↑ 8,595 5. TATA India Pharma & Healthcare Fund
CAGR/Annualized
return of 8.6% since its launch. Return for 2020 was 64.4% , 2019 was 5.5% and 2018 was -2.6% . TATA India Pharma & Healthcare Fund
Growth Launch Date 28 Dec 15 NAV (19 Jan 21) ₹15.1985 ↑ 0.26 (1.71 %) Net Assets (Cr) ₹419 on 31 Dec 20 Category Equity - Sectoral AMC Tata Asset Management Limited Rating Risk High Expense Ratio 2.61 Sharpe Ratio 1.95 Information Ratio 0.74 Alpha Ratio 14.53 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-3 Months (0.25%),3 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Dec 15 ₹10,000 31 Dec 16 ₹8,535 31 Dec 17 ₹8,932 31 Dec 18 ₹8,697 31 Dec 19 ₹9,176 31 Dec 20 ₹15,084 Returns for TATA India Pharma & Healthcare Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 19 Jan 21 Duration Returns 1 Month 1.9% 3 Month 12.1% 6 Month 30.5% 1 Year 58.6% 3 Year 19% 5 Year 9.4% 10 Year 15 Year Since launch 8.6% Historical performance (Yearly) on absolute basis
Year Returns 2020 64.4% 2019 5.5% 2018 -2.6% 2017 4.7% 2016 -14.7% 2015 2014 2013 2012 2011 Fund Manager information for TATA India Pharma & Healthcare Fund
Name Since Tenure Rahul Singh 20 Apr 20 0.7 Yr. Meeta Shetty 20 Apr 20 0.7 Yr. Data below for TATA India Pharma & Healthcare Fund as on 31 Dec 20
Equity Sector Allocation
Sector Value Health Care 96.89% Asset Allocation
Asset Class Value Cash 3.11% Equity 96.89% Top Securities Holdings / Portfolio
Name Holding Value Quantity Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 18 | 50012413% ₹56 Cr 107,600 Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Jan 16 | SUNPHARMA10% ₹41 Cr 690,100 Cipla Ltd (Healthcare)
Equity, Since 30 Apr 20 | 5000879% ₹38 Cr 460,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB8% ₹36 Cr 92,500 Narayana Hrudayalaya Ltd (Healthcare)
Equity, Since 29 Feb 20 | NH7% ₹29 Cr 656,720
↑ 30,000 Ipca Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 16 | 5244947% ₹27 Cr 125,426 Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 20 | ALKEM6% ₹26 Cr 89,200
↑ 20,200 Lupin Ltd (Healthcare)
Equity, Since 30 Nov 17 | 5002575% ₹20 Cr 203,000 Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Jul 18 | 5001264% ₹18 Cr 26,000 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 31 Dec 16 | APOLLOHOSP4% ₹17 Cr 70,500 6. Franklin India Technology Fund
CAGR/Annualized
return of 19.6% since its launch. Ranked 41 in Sectoral
category. Return for 2020 was 56.8% , 2019 was 12.4% and 2018 was 11.9% . Franklin India Technology Fund
Growth Launch Date 22 Aug 98 NAV (18 Jan 21) ₹273.988 ↓ -3.72 (-1.34 %) Net Assets (Cr) ₹472 on 31 Dec 20 Category Equity - Sectoral AMC Franklin Templeton Asst Mgmt(IND)Pvt Ltd Rating ☆ Risk High Expense Ratio 2.46 Sharpe Ratio 1.56 Information Ratio 0.57 Alpha Ratio 7.25 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Dec 15 ₹10,000 31 Dec 16 ₹9,737 31 Dec 17 ₹11,595 31 Dec 18 ₹12,978 31 Dec 19 ₹14,587 31 Dec 20 ₹22,867 Returns for Franklin India Technology Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 19 Jan 21 Duration Returns 1 Month 8.1% 3 Month 20.1% 6 Month 43.7% 1 Year 57.8% 3 Year 25.3% 5 Year 20% 10 Year 15 Year Since launch 19.6% Historical performance (Yearly) on absolute basis
Year Returns 2020 56.8% 2019 12.4% 2018 11.9% 2017 19.1% 2016 -2.6% 2015 3.8% 2014 16.8% 2013 53.3% 2012 0.3% 2011 -15.5% Fund Manager information for Franklin India Technology Fund
Name Since Tenure Anand Radhakrishnan 3 Mar 07 13.84 Yr. Varun Sharma 30 Nov 15 5.09 Yr. Mayank Bukrediwala 24 Aug 20 0.35 Yr. Data below for Franklin India Technology Fund as on 31 Dec 20
Equity Sector Allocation
Sector Value Technology 67.78% Communication Services 17.28% Consumer Cyclical 4.7% Industrials 2.36% Financial Services 0.64% Real Estate 0.24% Health Care 0.11% Asset Allocation
Asset Class Value Cash 6.7% Equity 93.14% Other 0.16% Top Securities Holdings / Portfolio
Name Holding Value Quantity Infosys Ltd (Technology)
Equity, Since 29 Feb 12 | INFY25% ₹119 Cr 945,647 Tata Consultancy Services Ltd (Technology)
Equity, Since 31 Aug 04 | TCS10% ₹49 Cr 170,000 HCL Technologies Ltd (Technology)
Equity, Since 30 Jun 14 | HCLTECH9% ₹43 Cr 450,000 Franklin Technology I Acc USD
Investment Fund | -8% ₹37 Cr 91,868 Bharti Airtel Ltd (Communication Services)
Equity, Since 31 Jan 18 | BHARTIARTL6% ₹31 Cr 600,000 Info Edge (India) Ltd (Communication Services)
Equity, Since 31 Jan 17 | NAUKRI5% ₹22 Cr 46,300 Tech Mahindra Ltd (Technology)
Equity, Since 28 Feb 14 | 5327555% ₹21 Cr 220,000 MakeMyTrip Ltd (Consumer Cyclical)
Equity, Since 31 Mar 20 | MMYT3% ₹13 Cr 60,135 Taiwan Semiconductor Manufacturing Co Ltd (Technology)
Equity, Since 30 Nov 18 | 23303% ₹12 Cr 88,000 Larsen & Toubro Infotech Ltd (Technology)
Equity, Since 30 Apr 19 | 5400052% ₹11 Cr 31,000
A perfect way to invest in the best equity mutual funds is by looking at its both qualitative and quantitative measures.
The credit of performance of a Mutual Fund scheme lies with the fund manager. A fund manager is responsible for making investment decisions for the fund’s portfolio. So, investors should go through the performance of the funds managed by the particular fund manager, especially during the tough market phases. Also, investors should give more priority to a fund manager who has an experience of managing a similar kind of funds, for example- small and mid caps. Going for a fund manager who has been consistent over his career is a preferred choice.
While choosing the best equity mutual funds to invest, always look at the quality & reputation of the fund house. A fund house with a long-standing record, large assets under management, star funds or good performing fund etc., is the one to invest in. Hence a fund house having a strong presence in the financial industry with a consistent track record should be ideally preferred.
An investor should do a fair assessment of the funds’ performances for over a period of time. Also, it is suggested to go for a fund that consistently beats its benchmark over 4-5 years, additionally, one should see each period and see if the fund is able to beat the benchmark or not.
Investors should always go for a fund that is neither too big nor too small in size. While there is no perfect definition and relation between the size of the fund, it is said that both too small and too large, can hinder a fund’s performance. Thus, while choosing a fund, it is advisable to go for the one whose AUM (Asset Under Management) is approximately same as the category.
Investors who have Mutual Fund Investments have to bear certain charges like operation costs, management fees, etc., charged by the Asset Management Company (AMC). Generally, the expense ratio is higher for schemes that are actively managed than it is for passively managed schemes (such as Index Funds or ETFs). As per the SEBI rules, an expense ratio for equity funds are a minimum of 2.5%.However, the expense ratio is something which should not supersede other important factors such as fund performance etc. It is better to pay a higher expense ratio in a fund knowing that it will beat it competitors by a good margin.
Some of the important ratios to measure fund performance are:
Alpha is a measure of the success of your investment or rather outperformance against the benchmark. It measures on how much the fund or stock has performed in the general market. A positive alpha of 1 means that the fund has outperformed its benchmark index by 1%, while a negative alpha of -1 would indicate that the fund has produced 1% lower returns than its market benchmark. So, basically, an investor’s strategy should be to buy securities with positive alpha.
It measures volatility in a stock’s price or fund relative to a benchmark and is denoted in positive or negative figures. A Beta of 1 signifies that the stock’s price moves in line with the market, beta of a greater than 1 designates that the stock is riskier than the market, and a beta of less than 1 means that the stock is less risky than the market. So, lower beta is better in a falling market. In a rising market, high-beta is better.
In simple terms, SD is a statistical measure representing the volatility or risk in an instrument. The higher the SD, higher will be the fluctuations in the returns.
Sharpe Ratio measures returns (both negative & positive) with respect to the risk taken. Here the risk is defined by the Standard Deviation. A higher Sharpe ratio means, a higher return without too much risk. Thus, while investing, investors should choose a fund that shows a higher Sharpe ratio.
The Sortino Ratio is a variation of Sharpe Ratio. But, unlike Sharpe ratio, Sortino ratio considers only the downside or negative return. Such a ratio is helpful for investors to assess risk in a better manner than just looking at the returns to the total volatility.
Upside/downside capture ratio guide an investor- whether a fund is outperformed i.e. gained more or lost less than a broad market benchmark- during the phase of the market upside (strong) or downside (weak), and more importantly by how much.
Well, an upside ratio of over 100 means that a given fund has beaten the benchmark during the period of positive returns. And a downside ratio of less than 100 shows that a given fund has lost less than its benchmark during the phase of dull returns. So, generally, investors should go for a fund that has a lower downside capture ratio and a higher upside capture ratio.
LTCGs exceeding INR 1 lakh arising from redemption of Mutual Fund units or equities will be taxed at 10 percent (plus cess) or at 10.4 percent. Long-term Capital Gains till INR 1 lakh will be exempt.
For example, if you earn INR 3 lakhs in combined long-term capital gains from stocks or Mutual Fund investments in a financial year. The taxable LTCGs will be INR 2 lakh (INR 3 lakh - 1 lakh) and tax liability will be INR 20,000 (10 per cent of INR 2 lakh).
Long-term capital gains are the profit arising from selling or redemption of equity funds held more than a year.
If Mutual Fund units are sold before one year of holding, Short Term Capital Gains (STCGs) tax will apply. The STCGs tax has been kept unchanged at 15 percent.
Equity Schemes | Holding Period | Tax Rate |
---|---|---|
Long Term Capital Gains (LTCG) | More than 1 Year | 10% (with no indexation)***** |
Short Term Capital Gains (STCG) | Less than or equal to a year | 15% |
Tax on Distributed Dividend | - | 10%# |
*Gains up to INR 1 lakh are free of tax. Tax at 10% applies to gains above INR 1 lakh.
#Dividend tax of 10% + Surcharge 12% + Cess 4% =11.648% Health & Education Cess of 4% introduced. Earlier, education Cess was 3%.
Open Free Investment Account for Lifetime at Fincash.com.
Complete your Registration and KYC Process
Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest!
While looking for best equity mutual funds, investors should choose equity funds which are doing well in the market. One should know how a fund behaves and performs when the market goes bad. A deep analysis of fund’s last three years’ performances is an ideal way to buy one of the best equity mutual funds.